Related Experiment Video
Updated: Jun 6, 2026

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
Complement activation by phospholipids: the interplay of factor H and C1q
Lee Aun Tan1, Bingbin Yu, Francis C J Sim
1MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Rd, Oxford OX13QU, UK.
Factor H, a complement inhibitor, also regulates the classical pathway by competing with C1q for binding to anionic phospholipids (aPL). This finding reveals a novel role for factor H in immune regulation beyond the alternative pathway.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Complement proteins recognize charged particles like anionic phospholipids (aPL).
- C1q activates the classical complement pathway, while factor H inhibits the alternative pathway.
- aPL, such as cardiolipin, bind both C1q and factor H.
Purpose of the Study:
- To investigate the opposing effects of C1q and factor H on complement activation by aPL.
- To determine if factor H regulates the classical complement pathway.
Main Methods:
- Surveying C1q and factor H binding to aPL coated on microtitre plates or in liposomes.
- Measuring complement activation by aPL.
- Adjusting the C1q:factor H molar ratio in human sera to measure C4 activation.
Main Results:
- Both C1q and factor H bound to all tested aPL and competed for binding.
- aPL activated the classical pathway but negligibly the alternative pathway.
- Factor H directly regulated classical pathway activation by competing with C1q for aPL binding.
Conclusions:
- Factor H acts as a direct regulator of the classical complement pathway by inhibiting C1q binding to aPL.
- This regulatory mechanism is distinct from factor H's role in the alternative pathway.
- Factor H has a novel role in downregulating classical complement pathway activation by aPL.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Related Concept Videos
Complement System
IP3/DAG Signaling Pathway
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...